Cat# CAU27311 Technical Documents: Available Citations: Target Name Target Synonyms Species Species Reactivity Host Clonality Immunogen IHC Validation Applications tid The Delta-Sleep Inducing Peptide (dSIP) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, ICC, IHC-P, IHC-F, ELISA
This hypothesis was supported by results that also OPC differentiation was significantly induced, axons were re-wrapped, and axonal damage was reduced after T4 treatment at the late stage of EAE (day 30 after onset), and that OPC differentiation significantly correlates with the neurological functional score (Zhang et al., 2016a)
Each batch undergoes analytical verification to support research integrity, including identity and purity testing through high-performance liquid chromatography (HPLC) and mass spectrometry
Then: Units on syringe = (Desired dose mg / Concentration) x 100
#manyo #manyopartner #kbeauty #prime #amazonprimeday | Elnaz Golrokh